{PDF} Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research: Workshop Summary Steve Olson and Adam C. Berger; Roundtable on Translating Genomic-Based Research for Health, Institute of Medicine

Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research.